P. Darmon et al., On the meaning of low-dose ACTH(1-24) tests to assess functionality of thehypothalamic-pituitary-adrenal axis, EUR J ENDOC, 140(1), 1999, pp. 51-55
To analyse further the ACTH(1-24) low-dose test, which is of clinical inter
est, we have examined the dose-response relationship between plasma ACTH(1-
24) and cortisol concentrations after i.v. administration of increasing dos
es (1, 5 or 250 mu g) of ACTH(1-24) as a bolus, In addition, we have measur
ed plasma ACTH(1-39) and cortisol levels after an insulin tolerance test (I
TT), Although there was a dose-response relationship between plasma ACTH(1-
24) immunoreactivity and the dose injected, cortisol peaks were comparable,
but lower than those reached after an ITT, Under these experimental condit
ions, an increase in plasma ACTH as low as 13 pmol/l (i.e. the increase obt
ained with the 1 mu g dose) induced a near maximal cortisol response. Follo
wing injection of 1 mu g ACTH(124), peak ACTH values were short lasting, si
milar to physiological daily bursts. After injection of 5 mu g ACTH(1-24),
plasma ACTH concentrations were higher than those reached during an ITT, bu
t clearly shorter lasting. Injection of 250 mu g ACTH(1-24) induced strikin
gly supraphysiological levels of plasma ACTH, Mie conclude that neither reg
ular nor low-dose ACTH tests can fully reproduce the ITT. Our observations
strongly suggest that the low-dose ACTH(1-24) test (1 mu g) can be useful t
o estimate the adrenal sensitivity under basal, physiological conditions.